Cargando…
Proteomic Footprinting of Drug-Treated Cancer Cells as a Measure of Cellular Vaccine Efficacy for the Prevention of Cancer Recurrence
The comparative proteomic study of cell surfaces of native and drug-treated cancer cells was performed. To this end, cell proteomic footprinting, which reflects the mass spectrometry profiling of cell surface proteins, was applied to breast adenocarcinoma cells (MCF-7), which were untreated or treat...
Autores principales: | Balashova, Elena E., Dashtiev, Maxim I., Lokhov, Petr G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society for Biochemistry and Molecular Biology
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3277770/ https://www.ncbi.nlm.nih.gov/pubmed/22074704 http://dx.doi.org/10.1074/mcp.M111.014480 |
Ejemplares similares
-
Cell Proteomic Footprinting: Advances in the Quality of Cellular and Cell-Derived Cancer Vaccines
por: Lokhov, Petr G., et al.
Publicado: (2023) -
Antigenic Essence: Upgrade of Cellular Cancer Vaccines
por: Lokhov, Petr G., et al.
Publicado: (2021) -
Cellular Cancer Vaccines: an Update on the Development of Vaccines Generated from Cell Surface Antigens
por: Lokhov, Petr G., et al.
Publicado: (2010) -
Changing Landscape of Cancer Vaccines—Novel Proteomics Platform for New Antigen Compositions
por: Lokhov, Petr G., et al.
Publicado: (2022) -
Allogeneic Antigen Composition for Preparing Universal Cancer Vaccines
por: Lokhov, Petr G., et al.
Publicado: (2016)